Osteonecrose medicamentosa em mandíbula: relato de caso
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
Drug-related osteonecrosis (ORM) is a serious and debilitating complication, the
incidence of which has increased in recent decades. It is defined as exposed bone in
the maxillofacial region that does not heal within eight weeks of identification by a
healthcare professional; with exposure to an antiresorptive or antiangiogenic agent;
and no history of radiotherapy to the craniofacial region. This condition is often
accompanied by pain, infection, and jaw dysfunction, and it can present from mild
symptoms to severe complications. Among the most commonly associated
medications are bisphosphonates. This study aims to describe a clinical case report of
a 60-year-old melanoderma, diabetic and hypertensive female patient with
osteonecrosis in the mandible, associated with the use of bisphosphonate. The clinical
characteristics, related risk factors, diagnosis and therapeutic management of the case
were discussed. It is a condition associated with several risk factors whose diagnosis
and treatment are challenging. The diagnosis requires a complete and detailed
evaluation, considering clinical and radiological aspects, medication history, and the
patient's health conditions. Treatment options can range from conservative
approaches to more invasive methods, depending on the severity of the disease.
However, a multidisciplinary and therapeutic approach is crucial for better prognosis
and to ensure effective and integrated management of the disease.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

